Livzon Pharmaceutical Group ( (HK:1513) ) has shared an announcement.
Livzon Pharmaceutical Group Inc. has announced an update regarding its final cash dividend for the year ended December 31, 2024. The dividend, set at RMB 11 per 10 shares, will be approved by shareholders on May 29, 2025, with an ex-dividend date of June 13, 2025, and a payment date of July 11, 2025. The announcement includes details on withholding tax rates applicable to different shareholder categories, indicating a 10% tax for non-resident enterprises and a 20% tax for resident individuals. This update reflects Livzon’s commitment to shareholder returns and provides clarity on the dividend distribution process, potentially impacting investor relations and market perception.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is known for its diverse range of healthcare solutions and has a significant market presence in China and internationally.
YTD Price Performance: -0.29%
Technical Sentiment Signal: Buy
Current Market Cap: $3.93B
Learn more about 1513 stock on TipRanks’ Stock Analysis page.